COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,503 Articles (22,866 medRxiv, 8,637 bioRxiv)

Most recent first Previous |  Page 182: Articles 1811-1820  | Next

Structural basis of SARS-Cov-2 spike recognition by engineered synthetic multivalent VHH antibodies
Lujan Hernandez, A. G., Laughlin, Z. T., Patel, A., Yuan, T. Z., Nugent, R. L., Axelrod, F., Ortlund, E. A., Sato, A. K.
10.1101/2024.10.02.616254 — Posted: 2024-10-02
Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses
Baillet, J., Klich, J. H., Ou, B. S., Meany, E. L., Yan, J., Bruun, T. U. J., Utz, A., Jons, C. K., Lecommandoux, S., Appel, E. A.
10.1101/2024.10.01.616060 — Posted: 2024-10-02
RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation
Ganguli, S., Gupta, D., Ramaswamy, R., Kodumuri, R. V., Krishnan, A. G., Tandel, D., David, D. T., Bunk, S., Chavali, S., Harshan, K. H., Chavali, P. L.
10.1101/2024.09.29.615653 — Posted: 2024-10-02
Bridging Cultures to Defeat COVID-19: An Innovative Virtual Exchange Program in Global Medical Education
Campagna, C. D., Searles, M. P., Suser, J. L., Omar, R. M. K., Bugaigis, H., Mansur, K. M. H., Imragaa, A., Dash, N. R., Saddik, B. W., Shennib, H., Chin, L. S., Perry, S. W.
10.1101/2024.09.30.24314434 — Posted: 2024-10-01
Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators
Ro, G., Lyngstad, T. M., Seppala, E., Skodvin, S. N., Trogstad, L., White, R. A., Paulsen, A., Paulsen, T. H., Ofitserova, T. S., Langlete, P., Madslien, E. H., Nygaard, K., Freisleben de Blasio, B.
10.1101/2024.09.30.24314638 — Posted: 2024-10-01
Change in Social Participation of Adults with Spinal Cord Injury During the First Two Waves of the COVID-19 Pandemic in Canada
Fortin-Bedard, N., Nindorera, F., Leblond, J., Rahn, C., Best, K. L., Borisoff, J., Sweet, S. N., Arbour-Nicitopoulos, K. P., Routhier, F.
10.1101/2024.09.30.24314551 — Posted: 2024-10-01
Brain-heart interactions are associated with mortality and acute encephalopathy in ICU patients with severe COVID-19
Hermann, B., Benghanem, S., Pruvost-Robieux, E., Sharshar, T., Gavaret, M., Cariou, A., Diehl, J.-L., Candia-Rivera, D.
10.1101/2024.10.01.24314706 — Posted: 2024-10-01
Teicoplanin attenuates RNA virus infection in vitro
Espano, E., Kim, J., Park, S. O., Padasas, B. T., Kim, S.-H., Son, J.-H., Oh, J., Woo, E.-E., Lee, Y.-R., Hwang, S. Y., Eo, S. K., Kim, J.-K.
10.1101/2024.09.29.615295 — Posted: 2024-10-01
Cxcl10 is required for survival during SARS-CoV-2 infection in mice
Majumdar, S., Weaver, J. D., Pontejo, S. M., Mahnaz, M., Lu, X., Gao, J.-L., Holmes, G., Johnson, R., Zhang, H., Kelsall, B. L., Farber, J. M., Alves, D. A., Murphy, P. M.
10.1101/2024.09.30.613319 — Posted: 2024-10-01
Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learning
Ferraz, M. V. F., Adan, W. C. S., Lima, T. E., Santos, A. J. C., de Paula, S. O., Dhalia, R., Wallau, G. L., Wade, R. C., Viana, I. F. T., Lins, R. D.
10.1101/2024.09.30.615772 — Posted: 2024-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).